BioSpace News Archive

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of T cell engagers to selectively modulate tumor-specific T cells, provided a business and financial update for the third quarter of 2023.

Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies, reported financial results for the third quarter ended September 30, 2023.

Lisata Therapeutics, Inc. announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present at the following conferences in November.

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today reported business updates and financial results for the third quarter of 2023.

Mineralys Therapeutics, Inc. announced that members of the senior management will be participating in the Stifel Healthcare Conference being held in New York on November 14-15, the Jefferies London Healthcare Conference being held in London on November 14-16, and the Evercore ISI 6th Annual HealthCONx Conference being held in Miami on November 28-30.

Neurocrine Biosciences, Inc., a leading neuroscience-focused biopharmaceutical company, announced Phase 2 study results from two signal-seeking pipeline programs in focal onset seizures and anhedonia.

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended September 30, 2023.

Aeglea BioTherapeutics, Inc. (“Aeglea” or the “Company”) (NASDAQ:AGLE) today announced its third quarter 2023 financial results and provided program and corporate updates.

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2023.

Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2023.